Work

Phase I trial of BMS-986253, an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.3091

Authors: Julie Marie Collins, Christopher Ryan Heery, Renee Nicole Donahue, Claudia Palena, Ravi Amrit Madan, Julius Strauss, Margaret Elena Gatti-Mays, Jeffrey Schlom, James L. Gulley, Marijo Bilusic

Institutions: National Cancer Institute, Bavarian Nordic (United States), National Institutes of Health, Georgetown University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890767638

Cites:

Cited by: 12

Related to: 10